Bollard Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6K Sell
86
-43
-33% -$2.83K ﹤0.01% 277
2026
Q1
$9K Hold
129
﹤0.01% 274
2025
Q4
$11K Sell
129
-43
-25% -$3.35K ﹤0.01% 259
2025
Q3
$13K Hold
172
﹤0.01% 233
2025
Q2
$13K Hold
172
﹤0.01% 253
2025
Q1
$14K Hold
172
﹤0.01% 245
2024
Q4
$13K Hold
172
﹤0.01% 246
2024
Q3
$16K Hold
172
﹤0.01% 263
2024
Q2
$13K Hold
172
﹤0.01% 264
2024
Q1
$16K Hold
172
﹤0.01% 254
2023
Q4
$13K Sell
172
-25
-13% -$1.75K ﹤0.01% 253
2023
Q3
$13K Hold
197
﹤0.01% 256
2023
Q2
$16K Buy
197
+25
+15% +$2K ﹤0.01% 264
2023
Q1
$14K Buy
+172
New +$12.3K ﹤0.01% 245

Other funds holding GEHC

Bollard Group's GEHC Position: Q2 2026 in Review

Bollard Group reduced its GE HealthCare (GEHC) stake by 33% in Q2 2026, selling an estimated $2.83K and leaving 86 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Bollard Group first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $16K in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bollard Group held 86 shares of GE HealthCare worth $6K as of Q2 2026.
  • Bollard Group sold 43 GE HealthCare shares in Q2 2026, an estimated $2.83K.
  • GE HealthCare made up ﹤0.01% of Bollard Group's portfolio in Q2 2026, its #277 holding.
  • Bollard Group first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Bollard Group's GE HealthCare position peaked at $16K in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.